CIK 0001497253 · Non-accelerated filer<br>Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271488943
- Phone
- 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-11-16 | KUSSMAN CRAIG Chief Financial Officer | Shares withheld for taxes | −14,720 | $1.07 | $16K | 333,103 |
| 2018-11-16 | Gallant Paul General Manager | Shares withheld for taxes | −9,450 | $1.07 | $10K | 220,519 |
| 2018-11-16 | CROUCH TAYLOR CEO & President | Shares withheld for taxes | −5,140 | $1.07 | $5K | 164,544 |
| 2018-11-16 | Bush Jennifer General Counsel & Secretary | Shares withheld for taxes | −11,915 | $1.07 | $13K | 281,588 |
| 2018-11-08 | Presnell Sharon Collins Chief Scientific Officer | Sale | −40,000 | $1.27 | $51K | 292,193 |
| 2018-08-16 | Presnell Sharon Collins Chief Scientific Officer | Shares withheld for taxes | −11,655 | $1.11 | $13K | 332,193 |
| 2018-08-16 | KUSSMAN CRAIG Chief Financial Officer | Shares withheld for taxes | −15,320 | $1.11 | $17K | 347,823 |
| 2018-08-16 | Gallant Paul General Manager | Shares withheld for taxes | −9,835 | $1.11 | $11K | 229,969 |
| 2018-08-16 | CROUCH TAYLOR CEO & President | Shares withheld for taxes | −5,350 | $1.11 | $6K | 169,684 |
| 2018-08-16 | Bush Jennifer General Counsel & Secretary | Shares withheld for taxes | −12,400 | $1.11 | $14K | 293,503 |
| 2018-08-15 | Presnell Sharon Collins Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +675,000 | 675,000 | ||
| 2018-08-15 | KUSSMAN CRAIG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +675,000 | 675,000 | ||
| 2018-08-15 | CROUCH TAYLOR CEO & President | Grant or award · Stock Option (right to Buy) | +1,350,000 | 1,350,000 | ||
| 2018-08-15 | Bush Jennifer General Counsel & Secretary | Grant or award · Stock Option (Right to Buy) | +675,000 | 675,000 | ||
| 2018-08-14 | Hughes Steven George Chief Medical Officer | Grant or award | +160,714 | 160,714 | ||
| 2018-08-14 | Hughes Steven George Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +974,694 | 974,694 | ||
| 2018-07-26 | Maroun Richard E Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,550 | ||
| 2018-07-26 | Malloy Kirk Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,550 | ||
| 2018-07-26 | KESSEL MARK Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,550 | ||
| 2018-07-26 | HOWSON TAMAR D Director | Grant or award · Stock Option (Right to Buy) | +45,500 | 45,550 |
Page 6 of 7 · 122 trades